Stereotactic Radiation Therapy
Sponsors
Sidney Kimmel Cancer Center at Thomas Jefferson University, Mayo Clinic, Stanford University, University of Louisville, GT Medical Technologies, Inc.
Conditions
Brain MetastasesBrain Metastases from Non-small Cell Lung CancerGlioblastomaGlioblastoma MultiformeNeuroma, AcousticNon Small Cell Lung CancerPatients Receiving Fractionated Stereotactic RadiotherapyUnspecified Adult Solid Tumor
Phase 1
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
TerminatedNCT00938457
Start: 2009-07-31Updated: 2016-05-19
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
RecruitingNCT04977375
Start: 2021-12-09End: 2026-12-31Target: 10Updated: 2025-09-03
Phase 2
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
Active, not recruitingNCT04786093
Start: 2021-07-27End: 2027-05-31Target: 52Updated: 2025-02-13
Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases
WithdrawnNCT04889066
Start: 2024-10-01End: 2025-01-31Updated: 2024-12-20
Phase 3
Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy
CompletedNCT00328510
Start: 2005-02-28End: 2009-09-30Updated: 2016-11-29
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
Active, not recruitingNCT04365374
Start: 2021-04-06End: 2029-08-30Target: 230Updated: 2025-10-07
Phase 4
Unknown Phase
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
CompletedNCT01129687
Start: 2005-03-31End: 2022-05-08Updated: 2022-05-10
Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis
TerminatedNCT01527292
Start: 2012-02-29End: 2015-09-02Updated: 2019-02-05